MedTrace Logo

Initial Resuscitation With Albumin in Hemorrhagic Shock to Reduce Positive Fluid Balance

NCT06111261 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2023-11-01

No results posted yet for this study

Summary

This study is designed to evaluate the effect of early albumin transfusion within massive transfusion protocol on fluid balance and reduced requirement of transfusion.

Conditions

  • Bleeding
  • Massive Hemorrhage
  • Massive Transfusion Protocol

Interventions

DRUG

Albumin solution

200ml of 20% Human Serum Albumin

DRUG

Balanced crystalloid solution

Balanced crystalloid solution

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Seung-young Oh, M.D. · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-15
Primary Completion
2025-07-15
Completion
2025-08-15

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06111261 on ClinicalTrials.gov